Posts

Showing posts from February, 2021

Conversion Labs: Telehealth Subscriptions

  Conversion Labs was highlighted in a bull call by Citron Research. The company is building a DTC health and wellness platform focused on subscription services. Q4 revenues surged 265% to $13.6 million. The stock is cheap compared to other telehealth brands trading at less than 5x EV/S multiples. This idea was discussed in more depth with members of my private investing community, Out Fox The Street.  Get started today » The telehealth space was hot in 2020 and Conversion Labs ( CVLB ) is playing perfectly into this trend. The company is quickly ramping up some new direct-to-consumer subscription services while building a telehealth platform for future products. The stock is appealing here after a notable firm made a bullish case on the stock. Read the full article on Seeking Alpha.  Update - March 18 A couple of weeks ago, LifeMD predicted Q1 revenue to reach $17 million. After the close, $HIMS reported a solid revenue beat for Q4. $LFMD reports after the close on the 29th.  -Him &a